Trial Profile
A prospective trial to evaluate the efficacy and safety of Plerixafor and G-CSF in patients with AL amyloidosis for stem cell mobilization before autologous stem cell transplantation
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 12 Oct 2014
Price :
$35
*
At a glance
- Drugs Plerixafor (Primary) ; Granulocyte colony-stimulating factors
- Indications Amyloidosis; Stem cell mobilisation
- Focus Therapeutic Use
- 12 Oct 2014 New trial record